Caricamento...
How to prevent the next Marathon Pharmaceuticals
In recent years, several drug companies have exploited U.S. regulatory policies to acquire exclusive rights to cheap therapies and substantially raise their prices, and Federal agencies and state governments are exploring various ways to prevent or punish such behavior in the future. Among these cas...
Salvato in:
| Pubblicato in: | F1000Res |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
F1000 Research Limited
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5865197/ https://ncbi.nlm.nih.gov/pubmed/29636900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.13678.1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|